THE EFFECT OF DILTIAZEM ON THE CORONARY HEMODYNAMIC AND CARDIAC FUNCTIONAL-EFFECTS PRODUCED BY INTRACORONARY ADMINISTRATION OF ENDOTHELIN-1 IN THE ANESTHETIZED DOG

被引:30
作者
NICHOLS, AJ
KOSTER, PF
OHLSTEIN, EH
机构
[1] Department of Pharmacology, SmithKline Beecham Pharm., King of Prussia, PA 19406
关键词
D O I
10.1111/j.1476-5381.1990.tb12975.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have studied the effect of the calcium channel antagonist, diltiazem, on the coronary haemodynamic and cardiac functional responses produced by intracoronary (i.c.) administration of endothelin-1 (ET-1) in anaesthetized dogs. ET-1, 1, 3 and 10 ng kg-1 i.c., produced dose-related increases in coronary blood flow with no cardiac functional or systemic haemodynamic changes. ET-1, 30, 100 and 300 ng kg-1 i.c., produced dose-related reductions in coronary artery blood flow. The reduction in coronary blood flow was accompanied by dose-related falls in cardiac output, mean arterial pressure, +dP/dt and -dP/dt and increases in left ventricular end-diastolic pressure. However, there was no reflex tachycardia in response to the fall in blood pressure and at 300 ng kg-1, ET-1 produced a 22% reduction in heart rate. Following a series of abnormal ECG changes, four out of five dogs died of ventricular fibrillation at 13 ± 2 min after 300 ng kg-1 ET-1. The administration of diltiazem (15 μg kg-1 min-1, i.v.) reduced mean arterial pressure by 10% and heart rate by 15%, and increased coronary blood flow by 39%. Diltiazem did not have any significant effect on the coronary dilator response to low doses of ET-1. Although there was a general trend for diltiazem to inhibit the coronary vasoconstrictor responses to ET-1, diltiazem significantly attenuated only the reduction in coronary blood flow produced by 100 ng kg-1 ET-1 by 60% but not the response to 30 or 300 ng kg-1 ET-1. Two out of five diltiazem-treated dogs died of ventricular fibrillation with a mean time to death of 20 min following treatment with ET-1 (300 kg-1). ET-1 is a very potent coronary vasodilator. At slightly higher doses ET-1 is also a coronary vasoconstrictor. ET-1 also appears to have direct cardiotoxicity independent of myocardial ischaemia. The vasoconstrictor activity and direct cardiotoxicity are only weakly inhibited by diltiazem.
引用
收藏
页码:597 / 601
页数:5
相关论文
共 23 条
[1]   EFFECTS OF ENDOTHELIN-1 ON THE RAT ISOLATED HEART [J].
BAYDOUN, AR ;
PEERS, SH ;
CIRINO, G ;
WOODWARD, B .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S193-S196
[2]   EFFECTS OF DILTIAZEM ON EXTENT OF ULTIMATE MYOCARDIAL INJURY RESULTING FROM TEMPORARY CORONARY-ARTERY OCCLUSION IN DOGS [J].
BUSH, LR ;
ROMSON, JL ;
ASH, JL ;
LUCCHESI, BR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (02) :285-296
[3]  
CHABRIER PE, 1989, J CARDIOVASC PHARM, V13, pS32
[4]   AUTORADIOGRAPHICAL LOCALIZATION OF BINDING-SITES FOR PORCINE [I-125] ENDOTHELIN-1 IN HUMANS, PIGS, AND RATS - FUNCTIONAL RELEVANCE IN HUMANS [J].
DAVENPORT, AP ;
NUNEZ, DJ ;
HALL, JA ;
KAUMANN, AJ ;
BROWN, MJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S166-S170
[5]  
GILLESPIE MN, 1986, J PHARMACOL EXP THER, V236, P339
[6]   CHARACTERIZATION OF A CORONARY VASOCONSTRICTOR PRODUCED BY CULTURED ENDOTHELIAL-CELLS [J].
HICKEY, KA ;
RUBANYI, G ;
PAUL, RJ ;
HIGHSMITH, RF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (05) :C550-C556
[7]   ENDOTHELIAL CELL-DERIVED VASOCONSTRICTORS - MECHANISMS OF ACTION IN VASCULAR SMOOTH-MUSCLE [J].
HIGHSMITH, RF ;
PANG, DC ;
RAPOPORT, RM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S36-S44
[8]   THE HUMAN ENDOTHELIN FAMILY - 3 STRUCTURALLY AND PHARMACOLOGICALLY DISTINCT ISOPEPTIDES PREDICTED BY 3 SEPARATE GENES [J].
INOUE, A ;
YANAGISAWA, M ;
KIMURA, S ;
KASUYA, Y ;
MIYAUCHI, T ;
GOTO, K ;
MASAKI, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2863-2867
[9]   THE POSSIBLE ROLE OF ENDOTHELIN-1 IN THE PATHOGENESIS OF CORONARY VASOSPASM [J].
KURIHARA, H ;
YOSHIZUMI, M ;
SUGIYAMA, T ;
YAMAOKI, K ;
NAGAI, R ;
TAKAKU, F ;
SATOH, H ;
INUI, J ;
YANAGISAWA, M ;
MASAKI, T ;
YAZAKI, Y .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S132-S137
[10]   EFFECTS OF ENDOTHELIN IN THE SYSTEMIC AND RENAL VASCULAR BEDS INVIVO [J].
LIPPTON, H ;
GOFF, J ;
HYMAN, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (1-2) :197-199